Vilon is one of the smallest peptide bioregulators in the Russian "cytogen" family — a synthetic dipeptide made of just two amino acids, lysine and glutamic acid (Lys-Glu, often written KE). It was developed by V.Kh. Khavinson's group and is chemically identical to one of the short peptides found inside thymalin, the thymus-extract immunocorrector used in Russian clinical practice. Its reputation is built on immune and geroprotective claims: that it can nudge an aging immune system back toward a younger profile and reduce the tumors that accumulate with age.
The most important thing to understand before weighing any of those claims is what Vilon actually is. Vilon is the isolated synthetic dipeptide. The broader human clinical story — decades of Russian use for age-related immune decline — largely belongs to the tissue extract thymalin, not to the two-amino-acid research chemical sold in vials online. The compound-specific evidence for Vilon itself is old, comes almost entirely from one research group, and is overwhelmingly rodent and cell-culture work with no independent Western replication. That gap between the extract's clinical reputation and the synthetic peptide's thin research base runs through everything below.
Research-context information only. Vilon is a research peptide. Protocols, doses, and reactions reported below come from published research and self-reported community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.
How Vilon Works
The proposed mechanism comes from Khavinson's group and is not independently established. In their model, Vilon is a peptide bioregulator: a very short peptide that is small enough to enter cells, bind regions of DNA and its associated proteins, and modulate which genes are switched on. This gene-expression hypothesis is the group's signature theory across the whole bioregulator family, and it should be read as a proposed mechanism, not a settled fact.
The most direct evidence offered for it is a 2002 study that used DNA-microarray technology to report that Vilon (and the pineal peptide epithalon) altered gene expression in mouse heart tissue (PMID 12360356). That study documents a molecular effect, but it was done in mouse tissue and measures gene-expression changes rather than any health outcome. For the practical side of administration, see the Vilon dosing guide.
One clarification prevents most of the confusion. Vilon (synthetic Lys-Glu) is a single defined dipeptide; thymalin is the crude thymus extract that contains Lys-Glu alongside other peptides. The two are routinely conflated in forum discussion, but they are not the same product, and the extract's clinical track record does not automatically validate the synthetic peptide.
Immune-Cell Effects: The Central Claim
The immune angle is the reason Vilon exists, and it is where the compound-specific data is least indirect — though "least indirect" here still means cell culture, not people. A 2013 study from Khavinson's group reported that Vilon and a close analogue increased the expression of the lymphocyte differentiation marker CD5 in cultured human and animal thymus cells (PMID 23486604). CD5 is a marker associated with T-cell development, so the result is consistent with the idea that Vilon pushes immune-cell maturation — but it was measured in a dish, and in-vitro signals frequently fail to translate to a working immune response in a living person.
The closest-to-human data point is an ex-vivo study in lymphocytes taken from elderly donors. Lezhava, Khavinson and colleagues reported that Vilon induced "deheterochromatinization" — a loosening of the tightly packed chromatin that accumulates in old cells — and reactivated ribosomal genes in those aged human lymphocytes (PMID 15105581). It is a striking cellular observation and the reason Vilon is described as "reactivating" aging immune cells. It is worth being precise about what it is, though: cells were treated in culture, not inside a person, and chromatin decondensation is a molecular marker, not a demonstrated clinical benefit.
Ready to buy? Compare verified vendors on our best Vilon sources page, or browse all coupon codes for up to 50% off.
